Collaborative Drug Therapy Management (CDTM)

Collaborative Drug Therapy Management (CDTM) allows qualified pharmacists to engage in a formal collaborative practice arrangement with a physician, so long as the pharmacist is practicing in facilities regulated by article twenty-eight of the public health law, including any diagnostic center, treatment center, or hospital-based outpatient departments (including outpatient clinics). This protocol-based arrangement, after being given consent by the patient, allows the pharmacist to adjust or manage a drug regimen for a specific disease or disease state.

CDTM has been successfully used throughout New York to improve patient care outcomes, improve medication adherence and decrease health care costs. The authority to engage in CDTM is set to sunset by July, 2022. Please inform your legislators of the importance of CDTM! Having to combat unnecessary sunset every two years is potentially stopping the robust development of these needed services. See fact sheet below.

Consent

With the rise of telehealth, the requirement that patients provide consent in writing has been challenging for some. The NYS Department of Health and Department of Education released guidance stating this consent may be made with the use of an electronic signature. Click HERE to review.

Collaborative Drug Therapy Management (CDTM)

2022 CDTM Fact Sheet
2021 CDTM Fact Sheet
2021 CDTM/Immunization FAQ's/Answers
NYSCHP CDTM Sample Letter 2021
CDTM during COVID-19 Survey
CDTM Bill Text (2021)
2015 CDTM Lobbying Presentation
2014 May CDTM Executive Summary
CDTM Video

Click HERE to check out this short video made by Lilia Davenport and others from the NYSCHP Grassroots Advocacy Chapter on CDTM!  

CDTM Example Documents:
CDTM Outcomes Data Collection Instructions
CDTM Outcome Spreadsheet
Consent Forms
Anticoagulation Service Collaborative Practice Agreement

CDTM Summit II – 2/27/[email protected] (Reference Documents):

Development of a CDTM Practice
Successful Implementation in Management of a CDTM Ambulatory Practice
Clinical Pearls:  Challenges in Managing a Collaborative Heart Failure Clinic
Clinical Peals:  Antimicrobials
An Update of the CDTM Law & Update on Outcomes Data and Metrics

Scope of Practice Advancement

NYSCHP believes that pharmacists should be able to practice at the top of their license. Unfortunately, state and federal laws/regulations restrict the care pharmacists are able to provide.

ASHP, in collaboration with other national pharmacy groups and state affiliates like NYSCHP, submitted extensive recommendations to CMS regarding the elimination of regulations that limit pharmacists from practicing at the top of their license. CMS requested additional input and recommendations under the Oct. 3, 2019, Executive Order “Protecting and Improving Medicare for Our Nation’s Seniors.” 

Comments to CMS regarding optimizing scope of practice for Pharmacists